Jessica Schiavi, FNP-BC Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 600 Atlantic Ave, Collingswood, NJ 08108 Phone: 856-854-1050 |
Mrs. Jennifer Wheeler, APN Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 600 Atlantic Ave, Collingswood, NJ 08108 Phone: 856-854-1050 |
Mr. Mieczyslaw Witek, MSN,CRNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 21 E Palmer Ave, Collingswood, NJ 08108 Phone: 856-858-1647 |
Jillian Hillman, Nurse Practitioner - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 117 Haddon Ave, Collingswood, NJ 08108 Phone: 856-217-5180 |
Ryan Samuel Wooden, NP Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 225 Haddon Ave, Collingswood, NJ 08108 Phone: 609-367-3466 |
Ms. Victoria Ines Munoz, RN,MSN,ANP,FNPC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 461 Haddon Ave, Collingswood, NJ 08108 Phone: 888-848-7437 |
News Archive
Imagine if you could attach something to your skin without needing glue. A biosensor, a watch, a communications device, a fashion accessory -; the possibilities are endless.
Issued at a meeting of Basel Convention and other world chemical authorities prior to UNEP's Governing Council meeting in Bali, Indonesia, the report, "Recycling - from E-Waste to Resources," used data from 11 representative developing countries to estimate current and future e-waste generation - which includes old and dilapidated desk and laptop computers, printers, mobile phones, pagers, digital photo and music devices, refrigerators, toys and televisions.
Following the first full face transplant in the U.S., one of the leading surgeons in the U.K. has announced that he's preparing to carry out a the world's second simultaneous face and hand transplant.
Investigators at the Cedars-Sinai Regenerative Medicine Institute have identified new molecular abnormalities in the diabetic cornea that could contribute to eye problems in affected patients. With this new knowledge, investigators aim to accelerate the process of healing and repair in damaged corneas to ultimately reverse the effects of diabetes-induced eye complications.
Wyeth Pharmaceuticals, a division of Wyeth has announced that the U.S. Food and Drug Administration (FDA) approved Tygacil (tigecycline), for the treatment of adult patients with community-acquired bacterial pneumonia (CABP) caused by susceptible strains of indicated pathogens.
› Verified 1 days ago